We have changed our domainWe have changed servers and operate Career|edu under a different domain. Our services will remain unchanged and we will continue to post the best career openings for the academic world at our new domain.
Go back to the Job List
Genome EngineeringPosted by: Postdoc positions by NIH
Posted date: 2020-Mar-18
A research opportunity is currently available in the Office of Tissues and Advanced Therapies (OTAT), at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
The goal of this project is to perform research and receive training on cell engineering with an emphasis on genome editing in human stem cells. Under the guidance of a mentor, the participant will be involved in research projects aimed to evaluate safety and efficacy of novel genome editing technologies for gene therapy, as well as to develop new therapeutic approaches. By precise genome editing, the projects also aim to understand cellular and molecular mechanisms in development and diseases, such as in the immune and hematopoietic systems.
The participant will receive mentoring on project design and execution, as well as training in specific techniques used in genome editing, stem cell maintenance and differentiation. Opportunities will also be provided to the participant to present and discuss research projects within the agency and in national research conferences.
Anticipated Appointment Start Date: May 1, 2020
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
The qualified candidate should have received a bachelor's, master's or doctoral degree in Engineering, Life Health and Medical Sciences, Nanotechnology or Chemistry, or be currently pursuing one of the degrees and will reach completion by May 1, 2020. Degree must have been received within five years of the appointment start date.
This opportunity is available to US citizens and Lawful Permanent Residents (LPR) only.To Apply:
A complete application consists of:
All documents must be in English or include an official English translation.
If you have questions, send an email to ORISE.FDA.CBERorau.org. Please include the reference code for this opportunity (FDA-CBER-2020-0018) in your email.
*Applications will be reviewed on a rolling-basis.
Application Deadline: February 24, 2021 3:00PM EST
This post will be available until June 18, 2020.
The NIH is dedicated to building a diverse community in its training and employment programs.